| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/18/2009 | US20090155234 Detection of mutations in a gene associated with resistance to viral infection, mx1 |
| 06/18/2009 | US20090155224 Dimethyl amino ethyl ether psoralens and methods for their production and use |
| 06/18/2009 | US20090155209 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155180 Methods and targets for identifying compounds for regulating rhinovirus infection |
| 06/18/2009 | US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/18/2009 | US20090155174 RNA Interference Mediating Small RNA Molecules |
| 06/18/2009 | CA2746551A1 Improved treatment and prophylaxis |
| 06/18/2009 | CA2709109A1 Methods and compositions for prevention or treatment of rsv infection |
| 06/18/2009 | CA2709021A1 Antibacterial condensed thiazoles |
| 06/18/2009 | CA2708793A1 Aminothiazoles and their uses |
| 06/18/2009 | CA2708241A1 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea |
| 06/18/2009 | CA2708150A1 Fluorinated tripeptide hcv serine protease inhibitors |
| 06/18/2009 | CA2708145A1 Compositions for inducing immune responses |
| 06/17/2009 | EP2071036A2 Methods for identifying RNA-binding compounds |
| 06/17/2009 | EP2071030A2 Oligoribonucleotide or peptide nucleic acid which inhibits action of hepatitis C virus |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070542A2 Method of extended culture of antigen-specific cyotoxic T lymphocytes |
| 06/17/2009 | EP2070536A1 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 06/17/2009 | EP2070527A1 Inhibitors of fungal biofilm-formation |
| 06/17/2009 | EP2069503A1 Papaya mosaic virus-based vaccines for influenza |
| 06/17/2009 | EP2069363A1 Rifaximin |
| 06/17/2009 | EP2069353A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 06/17/2009 | EP2069347A2 Novel inhibitors of beta-lactamase |
| 06/17/2009 | EP2069345A2 Pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 06/17/2009 | EP2069339A2 Substituted piperidinophenyl oxazolidinones |
| 06/17/2009 | EP2069301A1 Process for the preparation of pleuromutilins |
| 06/17/2009 | EP2068916A1 Vaccines against chlamydial infection |
| 06/17/2009 | EP2068890A2 Use of oritavancin for prevention and treatment of anthrax |
| 06/17/2009 | EP2068852A1 Antiviral compositions and use thereof |
| 06/17/2009 | EP2068834A2 Stable powder formulations of aluma-dsorbed vaccines |
| 06/17/2009 | EP1896386A4 Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria |
| 06/17/2009 | EP1866306B1 Imidazopyridine derivatives useful as inos inhibitors |
| 06/17/2009 | EP1789419B1 Gyrase inhibitors and uses thereof |
| 06/17/2009 | EP1712229B1 Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same |
| 06/17/2009 | EP1664046B1 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 06/17/2009 | EP1485381B1 Azolylaminoazine as inhibitors of protein kinases |
| 06/17/2009 | EP1472230B1 Ansamycins having improved pharmacological and biological properties |
| 06/17/2009 | EP1435786A4 Pesticidal formulations |
| 06/17/2009 | EP1390378B1 Pharmaceutically active uridine esters |
| 06/17/2009 | EP1383736B1 Peptide deformylase inhibitors |
| 06/17/2009 | EP1357115B1 Alkanoic acid derivatives, process for their production and use thereof |
| 06/17/2009 | EP1171428B1 Fab i inhibitors |
| 06/17/2009 | CN100500849C Expressing Ompk antigen of outer-membrane protein of Vibrio Harveyi and application as constituent of bacteria |
| 06/17/2009 | CN100500694C Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing same |
| 06/17/2009 | CN100500175C Pharmaceutical composition that contains eucalyptus and orange oil |
| 06/17/2009 | CN100500141C Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 06/16/2009 | US7547728 (N-(4-nitro-3-trifluoromethyl)phenyl)-(2S)-3-(4- (acetylamino) phenoxy)-2-hydroxy-2-methylpropanamide) derivatives |
| 06/16/2009 | US7547692 Rifamycin analogs and uses thereof |
| 06/16/2009 | US7547690 Compounds for the treatment of Hepatitis C |
| 06/16/2009 | US7547686 Combretastatin A-3 prodrug |
| 06/16/2009 | US7547682 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 06/16/2009 | US7547512 Nucleotide sequences comprisied of spike and nucleocapsid coding sequence for use as amplification tool in detection of coronaviral infection |
| 06/16/2009 | US7547442 Newcastle disease virus infectious clones, vaccines and new diagnostic assays |
| 06/16/2009 | US7547274 Radioactive member and method of making |
| 06/16/2009 | CA2574904C Antiretroviral enantiomeric nucleotide analogs |
| 06/16/2009 | CA2452217C Hiv inhibiting pyrimidines derivatives |
| 06/16/2009 | CA2399910C Mammalian secreted group iii phospholipase a2 |
| 06/16/2009 | CA2388314C Imidazole derivatives as phosphodiesterase vii inhibitors |
| 06/16/2009 | CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/16/2009 | CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 06/16/2009 | CA2340898C Compositions and methods for treating intracellular infections |
| 06/16/2009 | CA2330500C Pharmaceutical compositions capable of being gelled |
| 06/16/2009 | CA2192786C Cyclopeptolide inhibitors of adhesion molecules |
| 06/11/2009 | WO2009073133A1 Compositions of toll-like receptor agonists and papillomavirus antigens and uses thereof |
| 06/11/2009 | WO2009073056A1 Novel tetracycline derivatives as antibacterial agents |
| 06/11/2009 | WO2009072594A1 Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink |
| 06/11/2009 | WO2009072097A1 Antimicrobial compositions comprising fatty acids and milk proteins |
| 06/11/2009 | WO2009071959A2 Composition containing itraconazole |
| 06/11/2009 | WO2009071905A2 Use of thiolatocobalamins as regulators/selective promoters of inducible and constitutive nitric oxide synthases |
| 06/11/2009 | WO2009071731A1 Use of an ionic complex of gentamicin : aot for the treatment of brucellosis |
| 06/11/2009 | WO2009071730A1 Composition comprising gentamicin, an anionic surfactant and a copolymer |
| 06/11/2009 | WO2009071578A1 Composition based on probiotic bacteria in association with a prebiotic and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of intestinal functionality |
| 06/11/2009 | WO2009071480A2 Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors |
| 06/11/2009 | WO2009050390A3 Method for producing flu virus |
| 06/11/2009 | WO2009033818A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033787A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033786A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033759A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033740A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033722A3 Use of a octreotide as a therapeutic agent |
| 06/11/2009 | WO2009033719A3 Use of a deslorelin and mastoparan as a therapeutic agent |
| 06/11/2009 | WO2009030978A3 Conformers of bacterial adhesins |
| 06/11/2009 | WO2009008920A3 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning |
| 06/11/2009 | WO2003011214A3 Novel methods and formulations for administration of active agents |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149551 OXIDIZED cis-TERPENONE AND ITS USE AS A CHEMOPROTECTIVE AND ANTI-MALARIAL AGENT |
| 06/11/2009 | US20090149545 Treatment of coronavirus infection |
| 06/11/2009 | US20090149532 Herpesvirus-derived therapeutic agent for pain |
| 06/11/2009 | US20090149530 Antiinfective Flavonol Compounds and Methods of Use Thereof |
| 06/11/2009 | US20090149528 Cinnamic acid amides |
| 06/11/2009 | US20090149526 Tetracyclic Indole Derivatives as Antiviral Agents |
| 06/11/2009 | US20090149520 Oxazolidinones containing oxindoles as antibacterial agents |
| 06/11/2009 | US20090149510 Compositions and methods for modulating a kinase cascade |
| 06/11/2009 | US20090149509 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium; 2 (S)-hydroxy-3 (R)-[2 (S)-oxazol-2-yl-pyrrolidine-1-carbonyl)-heptanoic acid hydroxamide |
| 06/11/2009 | US20090149482 Stereochemically defined dipeptide esters of antiviral agents for enhanced ocular treatment |
| 06/11/2009 | US20090149473 Topical antifungal composition |
| 06/11/2009 | US20090149460 New Compounds |
| 06/11/2009 | US20090149459 P38 inhibitors and methods of use thereof |
| 06/11/2009 | US20090149449 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |